Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TSHA Taysha Gene Therapies, Inc.

未开盘 11-21 16:00:00 EST

2.18

+0.17

+8.46%

盘后2.21

+0.02+1.15%

18:35 EST

最高2.20	最低1.98	成交量527.82万
今开2.03	昨收2.01	日振幅10.95%
总市值4.47亿	流通市值2.75亿	总股本2.05亿
成交额1,124万	换手率4.19%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":2.18,"timestamp":1732222800000,"preClose":2.01,"halted":0,"volume":5278203,"hourTrading":{"tag":"盘后","latestPrice":2.205,"preClose":2.18,"latestTime":"18:35 EST","volume":2503495,"amount":5457441.2327,"timestamp":1732232133313},"delay":0,"floatShares":126092455,"shares":204943306,"eps":-0.096619,"marketStatus":"未开盘","marketStatusCode":0,"change":0.17,"latestTime":"11-21 16:00:00 EST","open":2.03,"high":2.2,"low":1.98,"amount":11236750.532091,"amplitude":0.109453,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.096619,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1600920000000,"adjPreClose":2.01,"preHourTrading":{"tag":"盘前","latestPrice":2.01,"preClose":2.01,"latestTime":"09:07 EST","volume":537,"amount":1073.1226494,"timestamp":1732198031444},"postHourTrading":{"tag":"盘后","latestPrice":2.205,"preClose":2.18,"latestTime":"18:35 EST","volume":2503495,"amount":5457441.2327,"timestamp":1732232133313},"volumeRatio":0.684618,"impliedVol":0.4847,"impliedVolPercentile":0.0754},"requestUrl":"/m/hq/s/TSHA/tweets","defaultTab":"tweets","newsList":[{"id":"2485417322","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.22%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485417322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485417322?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:07","pubTimestamp":1732208849,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时07分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅上涨5.22%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cidara Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Briacell Therapeutics Corp.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为915.59%、497.95%、370.00%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010729971a7ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010729971a7ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2485423941","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485423941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485423941?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:29","pubTimestamp":1732120154,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时29分，Taysha Gene Therapies, Inc.股票出现异动，股价急速跳水5.18%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1328.32%、1185.06%、403.79%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、96.91%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121002915abd2675b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121002915abd2675b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2484923583","title":"Taysha Gene Therapies, Inc.盘中异动 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484923583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484923583?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:33","pubTimestamp":1732026832,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时33分，Taysha Gene Therapies, Inc.股票出现波动，股价急速跳水5.26%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Exicure, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为637.23%、79.34%、64.70%，振幅较大的相关个股有Tff Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Invizyne Technologies Inc.，振幅分别为30.22%、28.79%、23.08%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223352971a76b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223352971a76b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2484767980","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484767980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484767980?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:34","pubTimestamp":1731940487,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时34分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅拉升5.10%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为524.88%、232.81%、197.11%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为67.89%、45.05%、34.31%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223447abccafc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223447abccafc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2483303634","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483303634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483303634?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:40","pubTimestamp":1731681649,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时40分，Taysha Gene Therapies, Inc.股票出现波动，股价快速下挫5.07%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2872.62%、211.88%、177.28%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.，振幅分别为125.68%、114.92%、62.87%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522405098e42f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522405098e42f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2483589217","title":"泰沙基因治疗公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483589217","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483589217?lang=zh_cn&edition=full","pubTime":"2024-11-14 12:05","pubTimestamp":1731557158,"startTime":"0","endTime":"0","summary":"泰沙基因治疗公司报告本季度业绩 - 收益摘要Taysha Gene Therapies Inc TSHA.OQ报告本季度调整后每股亏损10美分，高于去年同期的每股-13美分。11位分析师对该季度的平均预期是每股亏损9美分。该公司当季亏损 2552 万美元。Taysha Gene Therapies Inc的股价本季度上涨了18.9%，今年迄今为止上涨了35.0%。华尔街对泰沙基因治疗公司 12 个月目标价的中位数为 7.00 本摘要由 LSEG 11 月 14 日上午 04:05 时的调制解调器器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML0E0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2483884562","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.86%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884562?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508378,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅拉升5.86%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为331.39%、178.92%、85.09%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Kairos Pharma, Ltd.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、14.12%、11.44%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223258971a647a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223258971a647a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2482922714","title":"泰沙基因治疗公司预计每股亏损9美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482922714","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482922714?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:46","pubTimestamp":1731383190,"startTime":"0","endTime":"0","summary":"泰沙基因治疗公司预计每股亏损9美分 - 财报前瞻泰沙基因治疗公司TSHA.OQTSHA.O预计将在11月13日公布截至2024年9月30日的季度业绩报告时显示季度收入下降。LSEG 分析师对 Taysha Gene Therapies Inc 的平均预期是每股亏损 9 美分。华尔街对 Taysha Gene Therapies Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 1.63 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ0BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2482757743","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482757743?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:50","pubTimestamp":1731354622,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日03时50分，Taysha Gene Therapies, Inc.股票出现异动，股价快速拉升5.00%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Aligos Therapeutics, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为846.19%、512.57%、287.52%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为132.14%、72.42%、65.93%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111203502298e41dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111203502298e41dfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2482480594","title":"Taysha Gene Therapies, Inc.盘中异动 大幅拉升5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482480594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482480594?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:14","pubTimestamp":1731086071,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时14分，Taysha Gene Therapies, Inc.股票出现波动，股价快速上涨5.63%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为701.85%、66.79%、55.43%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为102.22%、87.00%、52.00%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109011431971a56de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109011431971a56de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2481600020","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速上涨7.09%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481600020?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903513,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Taysha Gene Therapies, Inc.股票出现波动，股价大幅上涨7.09%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Macrogenics, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1032.56%、98.35%、49.49%，振幅较大的相关个股有Vaxcyte, Inc.、Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.，振幅分别为107.85%、107.84%、106.06%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622315498e40d99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622315498e40d99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2481203531","title":"Taysha Gene Therapies, Inc.盘中异动 快速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481203531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481203531?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:24","pubTimestamp":1730741048,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时24分，Taysha Gene Therapies, Inc.股票出现波动，股价快速跳水5.16%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为352.15%、274.99%、79.03%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012408a21595aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012408a21595aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2480835020","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480835020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480835020?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:46","pubTimestamp":1730476007,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时46分，Taysha Gene Therapies, Inc.股票出现异动，股价急速下跌5.03%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为3442.74%、830.74%、776.54%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、96.49%、60.77%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123464898e400cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123464898e400cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2479038173","title":"Taysha Gene Therapies, Inc.盘中异动 大幅下挫5.08%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479038173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479038173?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:49","pubTimestamp":1730382559,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时49分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅跳水5.08%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为2.37%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为210.69%、200.76%、152.88%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为39.30%、28.17%、21.98%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214919971a38b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214919971a38b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2477307203","title":"Taysha Gene Therapies, Inc.盘中异动 早盘大幅下挫5.94%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477307203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477307203?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:02","pubTimestamp":1729605777,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时02分，Taysha Gene Therapies, Inc.股票出现异动，股价大幅下挫5.94%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3607.22%、2333.71%、1760.16%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为140.78%、99.41%、67.84%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022220257971a19e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022220257971a19e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2475017914","title":"Taysha Gene Therapies, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475017914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475017914?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:12","pubTimestamp":1729091523,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时12分，Taysha Gene Therapies, Inc.股票出现波动，股价快速上涨5.13%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5892.71%、1063.64%、423.92%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为623.68%、279.52%、126.58%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623120398e3ccfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623120398e3ccfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2469917146","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469917146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469917146?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:06","pubTimestamp":1727104006,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时06分，Taysha Gene Therapies, Inc.股票出现波动，股价急速跳水5.12%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为251.48%、46.60%、44.30%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Black Diamond Therapeutics, Inc.，振幅分别为42.83%、42.78%、25.84%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230646a1dbf07f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230646a1dbf07f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2468046725","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.35%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468046725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468046725?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:38","pubTimestamp":1726760281,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时38分，Taysha Gene Therapies, Inc.股票出现异动，股价急速拉升5.35%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体涨幅为1.70%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4293.69%、808.73%、184.51%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.31%、78.69%、52.97%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233801ab64a74c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233801ab64a74c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2468847698","title":"Taysha Gene Therapies, Inc.盘中异动 大幅下跌5.02%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468847698?lang=zh_cn&edition=full","pubTime":"2024-09-17 00:11","pubTimestamp":1726503078,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日00时11分，Taysha Gene Therapies, Inc.股票出现异动，股价快速跳水5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Nucana Plc、Surrozen Inc C/Wts 01/08/2031 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Nucana Plc、Dermata Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为1905.62%、1600.81%、966.74%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nucana Plc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为117.33%、69.69%、47.50%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917001118ab64041a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917001118ab64041a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2467170335","title":"Taysha Gene Therapies, Inc.盘中异动 快速拉升5.02%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467170335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467170335?lang=zh_cn&edition=full","pubTime":"2024-09-14 00:21","pubTimestamp":1726244486,"startTime":"0","endTime":"0","summary":"北京时间2024年09月14日00时21分，Taysha Gene Therapies, Inc.股票出现波动，股价快速拉升5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Instil Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为902.20%、407.46%、110.48%，振幅较大的相关个股有Instil Bio, Inc.、Immuneering Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为52.63%、51.75%、48.21%。Taysha Gene Therapies, Inc.公司简介：Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司，旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140021269719b567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140021269719b567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":-0.0396},{"period":"1month","weight":0.0955},{"period":"3month","weight":-0.0091},{"period":"6month","weight":-0.3272},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.2316}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司，致力于开发和开发商业化基于AAV的基因疗法，用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.188381},{"month":2,"riseRate":0.25,"avgChangeRate":0.120073},{"month":3,"riseRate":0.25,"avgChangeRate":-0.121311},{"month":4,"riseRate":0.25,"avgChangeRate":-0.087217},{"month":5,"riseRate":0.25,"avgChangeRate":-0.029549},{"month":6,"riseRate":0.25,"avgChangeRate":-0.00003},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021321},{"month":8,"riseRate":0.75,"avgChangeRate":0.9233},{"month":9,"riseRate":0,"avgChangeRate":-0.14195},{"month":10,"riseRate":0,"avgChangeRate":-0.151796},{"month":11,"riseRate":0.6,"avgChangeRate":0.048877},{"month":12,"riseRate":0.75,"avgChangeRate":0.024785}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}